1. Amiselimod, a novel sphingosine 1‐phosphate receptor‐1 modulator, has potent therapeutic efficacy for autoimmune diseases, with low bradycardia risk. (17th November 2016) Authors: Sugahara, Kunio; Maeda, Yasuhiro; Shimano, Kyoko; Mogami, Akira; Kataoka, Hirotoshi; Ogawa, Kei; Hikida, Kumiko; Kumagai, Hiroshi; Asayama, Mahoko; Yamamoto, Toshinobu; Harada, Tomohiko; Ni, Pingping; Inoue, Shinsuke; Kawaguchi, Atsuhiro Journal: British journal of pharmacology Issue: Volume 174:Number 1(2017:Jan.) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗